Med Chem 3 Flashcards
5) Natural ligand (e.g. for receptor)
5-HT, 5-hydroxytryptamine was the starting point for the development of 5-HT1 agonist, Sumatriptan
Endogenous compounds as drugs
so compounds that are naturally occurring in the body e.g. hormones, neurotransmitters etc.
1) Neurotransmitters
2) Hormones
3) Peptides in drugs
4) Peptidomimetics
Endogenous compounds as drugs 1) Neurotransmitters
- would not survive stomach acids
- body efficiently removes them
- hard to direct to one target in the body (therefore have side effects)
Medicinal chemists use receptor subtypes that are common to the specific tissues - in this way, the chemist is ahead of Nature!
Endogenous compounds as drugs
2) Hormones
- most are peptides & proteins (e.g. insulin)
- susceptible to metabolic breakdown
Endogenous compounds as drugs
3) Peptides in drugs
Goserelin (Zoladex)
$700 million / year - used for breast and prostate cancer (given by subcutaneous injection)
Endogenous compounds as drugs
4) Peptidomimetics
Modifications to the peptide bond:
- Alkene - still provides rigidity
- Ketone - maintains C=O
- Amine - maintains N-H
- N-methylation - analogue without H-donor
If activity is retained we have a bioisostere
6) Combinatorial chemistry (combi-chem)
- To match advances in genomics and proteomics
- Automated solid-phase procedure
- Many structures in less time
- Small scale reactions
- Artificial production to try and compete with nature
The current approach to lead compounds….
Combinatorial synthesis answers the explosion in the number of drug targets
‘finding a lead was becoming the limiting factor in the pharmaceutical industry’
‘produce 1000’s or millions of novel structures in the same time as a dozen by conventional means’
7) Computer aided design
§ Useful if we are able to crystallize the enzyme or receptor
§ X-ray crystallography - a very powerful tool
§ Gain a detailed knowledge of the target binding site
§ Model software allows us to dock a variety of structures into the binding pocket
Drawback! Need the crystal structure for accurate interpretation. This is very tricky!!
Docking ….
The DOCK program - defines space in the binding site using spheres
- The spheres, which can overlap with one another, must touch the molecular surface twice (& twice only)
Pharmacophore ID….
Pharmacophore = structure that has the important binding groups in the correct position
De novo design….
- involves the design of novel structures based on the structure of the intended binding site
§ This technique was conceived approx. 20 years ago
§ Supplies novel pharmaceutical agents
§ Is a cost and time efficient process
§ A complement to other virtual techniques (e.g. database searching)
Predictive ADMET studies….
ADMET = Absorption, distribution, metabolism, elimination and toxicology
This predictive computational technique is described as, the new ‘hip’ area in drug design
Three stages of optimization at a kinase active site….
- Empty pocket
- mM hit bound
- nM lead compound
Optimization is based on information relating to the 3D shape and chemical nature of the active pocket
An anti-target
is a protein with similar structures that chemists
should design away from in order to avoid unintentional
interactions & potential side effects.
Can compare, electrostatic charge distribution, flexibility, hydrophobicity, strain energy etc.